Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
Otávio Cabral-Marques, Gilad Halpert, Lena F. Schimke, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

The immunology of long COVID
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 255
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms
Kiho Son, Rameen Jamil, Abhiroop Chowdhury, et al.
European Respiratory Journal (2022), pp. 2200970-2200970
Open Access | Times Cited: 167
Long COVID: pathophysiological factors and abnormalities of coagulation
Simone Turner, Asad Khan, David Putrino, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 6, pp. 321-344
Open Access | Times Cited: 141
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 80
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
Franziska Sotzny, Igor Salerno Filgueiras, Claudia Kedor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023
Jan Willem Cohen Tervaert, Manuel Martı́nez-Lavı́n, Luis J. Jara, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103287-103287
Open Access | Times Cited: 70
Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches
Tihamér Molnár, Andrea Lehoczki, Mónika Fekete, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 5267-5286
Open Access | Times Cited: 27
Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19
Chisa Matsumoto, Shigeru Shibata, Takuya Kishi, et al.
Hypertension Research (2022) Vol. 46, Iss. 3, pp. 601-619
Open Access | Times Cited: 42
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States
Lena F. Schimke, Alexandre H. C. Marques, G. Baiocchi, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 847-847
Open Access | Times Cited: 39
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
Otávio Cabral-Marques, Guido Moll, Rusan Catar, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103310-103310
Closed Access | Times Cited: 32
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis
Martin Achleitner, Charlotte Steenblock, Juliane Dänhardt, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2872-2877
Open Access | Times Cited: 27
Is fibromyalgia an autoimmune disorder?
Daniel J. Clauw, Piercarlo Sarzi‐Puttini, Greta Pellegrino, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 1, pp. 103424-103424
Open Access | Times Cited: 27
Autoimmunity in Long Covid and POTS
Fatema-Zahra El-Rhermoul, Artur Fedorowski, Philip Eardley, et al.
Oxford Open Immunology (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 26
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
Dennyson Leandro M. Fonseca, Igor Salerno Filgueiras, Alexandre H. C. Marques, et al.
npj Aging (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients
Y. Lavi, Aristo Vojdani, Gilad Halpert, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 687-687
Open Access | Times Cited: 21
Role of Endothelium in Cardiovascular Sequelae of Long COVID
L. Santoro, Vincenzo Zaccone, Lorenzo Falsetti, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2239-2239
Open Access | Times Cited: 21
Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors
Felix S. Seibert, Ulrik Stervbo, Lea Wiemers, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 11, pp. 103445-103445
Open Access | Times Cited: 19
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity
G. Baiocchi, Aristo Vojdani, Avi Z. Rosenberg, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 18
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 18
Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
Varvara A. Ryabkova, Natalia Gavrilova, Alina A. Poletaeva, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 257-257
Open Access | Times Cited: 17
Modern concept of autoimmunity in rheumatology
Е. Л. Насонов
Rheumatology Science and Practice (2023) Vol. 61, Iss. 4, pp. 397-420
Open Access | Times Cited: 16
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 7
Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching
Xiaoyang Yue, Junping Yin, Xiaoqing Wang, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 9, pp. 1281-1289
Open Access | Times Cited: 27
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases
Maria Giovanna Danieli, Alessandro Tonacci, Alberto Paladini, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 6, pp. 103105-103105
Closed Access | Times Cited: 26
Multiplexed selectivity screening of anti-GPCR antibodies
Leo Dahl, Ilana B. Kotliar, Annika Bendes, et al.
Science Advances (2023) Vol. 9, Iss. 18
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top